Cross-Sector entity
All 1 tracked stories fall under one category: pharma. CBER is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 6 original sources on average. We currently track 1 Cross-Sector story that mention Vaccine Chief, all published on March 7, 2026.
1 verified story tracked
Last mentioned: Mar 7, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. CBER is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 6 original sources on average. We currently track 1 Cross-Sector story that mention Vaccine Chief, all published on March 7, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vaccine Chief. Shared-story counts are live from our verified record — not editorial picks.
The head of the FDA’s vaccine division is stepping down for the second time, marking a significant leadership vacuum at a critical juncture for the agency. This departure follows a period of intense scrutiny and reported friction between the regulatory body and the Trump administration over vaccine authorization protocols.
